Recruiting OBSERVATIONAL NCT05156736

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults (PAKSEHAT)

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults (PAK SEHAT)

Sponsor: Getz Pharma

Conditions Atherosclerotic Plaque Diabetes Mellitus, Type 2 Hypertension Stroke

Updated 4 times since 2022 Last updated: Apr 5, 2023 Started: Mar 15, 2023 Primary completion: Feb 29, 2028 Completion: Nov 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atherosclerotic Plaque and Diabetes Mellitus, Type 2 and is currently actively recruiting participants. Getz Pharma leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2023 — Jul 2024 [monthly]

Recruiting
Jan 2022 — May 2023 [monthly]

Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Getz Pharma
Tabba Heart Institute

Data source: Tabba Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan